Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) Investment Income, Interest

3.1 / 5 stars · 36/58 Roast Me

CASTLE BIOSCIENCES, INC. Investment Income, Interest

CASTLE BIOSCIENCES, INC. (CSTL) reported Investment Income, Interest of $2.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2026-07-30

  • CASTLE BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-06-30 was $2.36M, a 19.97% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-03-31 was $2.54M, a 17.88% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-12-31 was $2.90M, a 14.12% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-09-30 was $2.83M, a 16.77% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. investment income, interest for fiscal 2025 was $11.77M, a 8.86% decline from fiscal 2024.
  • CASTLE BIOSCIENCES, INC. investment income, interest for fiscal 2024 was $12.92M, a 21.59% increase from fiscal 2023.
  • CASTLE BIOSCIENCES, INC. investment income, interest for fiscal 2023 was $10.62M, a 167.72% increase from fiscal 2022.
  • CASTLE BIOSCIENCES, INC. investment income, interest for fiscal 2022 was $3.97M, a 5735.29% increase from fiscal 2021.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 3 month as first filedInvestment Income, Interest 6 monthInvestment Income, Interest 6 month as first filedInvestment Income, Interest 9 monthInvestment Income, Interest 9 month as first filedInvestment Income, Interest 12 month
2026-06-30$2.36M
10-Q · filed 2026-07-30
$4.90M
10-Q · filed 2026-07-30
$7.80M
derived: sum of 3 quarters · filed 2026-07-30
$10.63M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$2.54M
10-Q · filed 2026-05-06
$5.44M
derived: sum of 2 quarters · filed 2026-05-06
$8.27M
derived: sum of 3 quarters · filed 2026-05-06
$11.22M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.73M
derived: sum of 2 quarters · filed 2026-02-26
$8.67M
derived: sum of 3 quarters · filed 2026-07-30
$11.77M
10-K · filed 2026-02-26
2025-09-30$2.83M
10-Q · filed 2025-11-03
$5.78M
derived: sum of 2 quarters · filed 2026-07-30
$8.88M
10-Q · filed 2025-11-03
$12.25M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$2.94M
10-Q · filed 2026-07-30
$6.04M
10-Q · filed 2026-07-30
$9.41M
derived: sum of 3 quarters · filed 2026-07-30
$12.82M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$3.10M
10-Q · filed 2026-05-06
$6.47M
derived: sum of 2 quarters · filed 2026-05-06
$9.88M
derived: sum of 3 quarters · filed 2026-05-06
$13.02M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.78M
derived: sum of 2 quarters · filed 2026-02-26
$9.92M
derived: sum of 3 quarters · filed 2026-02-26
$12.92M
10-K · filed 2026-02-26
2024-09-30$3.40M
10-Q · filed 2025-11-03
$6.55M
derived: sum of 2 quarters · filed 2025-11-03
$9.54M
10-Q · filed 2025-11-03
$12.66M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$3.14M
10-Q · filed 2025-08-04
$6.14M
10-Q · filed 2025-08-04
$9.26M
derived: sum of 3 quarters · filed 2026-02-26
$12.03M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$3.00M
10-Q · filed 2025-05-05
$6.12M
derived: sum of 2 quarters · filed 2026-02-26
$8.88M
derived: sum of 3 quarters · filed 2026-02-26
$11.28M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.89M
derived: sum of 2 quarters · filed 2026-02-26
$8.29M
derived: sum of 3 quarters · filed 2026-02-26
$10.62M
10-K · filed 2026-02-26
2023-09-30$2.77M
10-Q · filed 2024-11-04
$5.17M
derived: sum of 2 quarters · filed 2024-11-04
$7.50M
10-Q · filed 2024-11-04
$9.78M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$2.40M
10-Q · filed 2024-08-05
$4.74M
10-Q · filed 2024-08-05
$7.01M
derived: sum of 3 quarters · filed 2025-02-27
$8.30M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$2.34M
10-Q · filed 2024-05-02
$4.61M
derived: sum of 2 quarters · filed 2025-02-27
$5.90M
derived: sum of 3 quarters · filed 2025-02-27
$6.27M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$3.57M
derived: sum of 2 quarters · filed 2025-02-27
$3.94M
derived: sum of 3 quarters · filed 2025-02-27
$3.97M
10-K · filed 2025-02-27
2022-09-30$1.29M
10-Q · filed 2023-11-02
$1.66M
derived: sum of 2 quarters · filed 2023-11-02
$1.69M
10-Q · filed 2023-11-02
$1.71M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$370.00K
10-Q · filed 2023-08-02
$400.00K
10-Q · filed 2023-08-02
$417.00K
derived: sum of 3 quarters · filed 2023-08-02
$440.00K
derived: sum of 4 quarters · filed 2023-08-02
2022-03-31$30.00K
10-Q · filed 2023-05-03
$47.00K
derived: sum of 2 quarters · filed 2023-05-03
$70.00K
derived: sum of 3 quarters · filed 2023-05-03
$94.00K
derived: sum of 4 quarters · filed 2023-05-03
2021-12-31$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$40.00K
derived: sum of 2 quarters · filed 2023-02-28
$64.00K
derived: sum of 3 quarters · filed 2023-02-28
$68.00K
10-K · filed 2023-02-28
2021-09-30$23.00K
10-Q · filed 2022-11-02
$47.00K
derived: sum of 2 quarters · filed 2022-11-02
$51.00K
10-Q · filed 2022-11-02
$70.00K
derived: sum of 4 quarters · filed 2022-11-02
2021-06-30$24.00K
10-Q · filed 2022-08-08
$28.00K
10-Q · filed 2022-08-08
$47.00K
derived: sum of 3 quarters · filed 2022-08-08
$65.00K
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$4.00K
10-Q · filed 2022-05-09
$23.00K
derived: sum of 2 quarters · filed 2022-05-09
$41.00K
derived: sum of 3 quarters · filed 2022-05-09
$79.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$37.00K
derived: sum of 2 quarters · filed 2022-02-28
$75.00K
derived: sum of 3 quarters · filed 2022-02-28
$373.00K
10-K · filed 2022-02-28
2020-09-30$18.00K
10-Q · filed 2021-11-08
$56.00K
derived: sum of 2 quarters · filed 2021-11-08
$354.00K
10-Q · filed 2021-11-08
$634.00K
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$38.00K
10-Q · filed 2021-08-09
$336.00K
10-Q · filed 2021-08-09
$616.00K
derived: sum of 3 quarters · filed 2021-08-09
$622.00K
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31$298.00K
10-Q · filed 2021-05-10
$578.00K
derived: sum of 2 quarters · filed 2021-05-10
$584.00K
derived: sum of 3 quarters · filed 2021-05-10
$589.00K
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31$280.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$286.00K
derived: sum of 2 quarters · filed 2021-03-11
$291.00K
derived: sum of 3 quarters · filed 2021-03-11
$312.00K
10-K · filed 2021-03-11
2019-09-30$6.00K
10-Q · filed 2020-11-09
$5.19K
10-Q · filed 2019-11-12
$11.00K
derived: sum of 2 quarters · filed 2020-11-09
$32.00K
10-Q · filed 2020-11-09
$31.51K
10-Q · filed 2019-11-12
$35.11K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$5.00K
10-Q · filed 2020-08-10
$5.53K
10-Q · filed 2019-09-03
$26.00K
10-Q · filed 2020-08-10
$26.32K
10-Q · filed 2019-09-03
$29.11K
derived: sum of 3 quarters · filed 2020-08-10
$42.38K
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$21.00K
10-Q · filed 2020-05-11
$24.11K
derived: sum of 2 quarters · filed 2020-05-11
$37.38K
derived: sum of 3 quarters · filed 2020-05-11
$39.62K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$3.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$16.38K
derived: sum of 2 quarters · filed 2020-03-10
$18.62K
derived: sum of 3 quarters · filed 2020-03-10
$24.00K
10-K · filed 2020-03-10
2018-09-30$13.27K
10-Q · filed 2019-11-12
$15.51K
derived: sum of 2 quarters · filed 2019-11-12
$20.89K
10-Q · filed 2019-11-12
2018-06-30$2.24K
10-Q · filed 2019-09-03
$7.62K
10-Q · filed 2019-09-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B